This department is offering a grant to support the further development and validation of advanced technologies improving the quality of biospecimens used in cancer research and clinical care. The grant seeks to bridge feasibility gaps in technologies that address pre-analytical degradation of targeted analytes in cancer-relevant samples. It aims to encourage the adoption of innovative tools and methods that enhance sample integrity, quality assessment, and control, ultimately advancing research in cancer biology, early detection, clinical diagnosis, and treatment. This opportunity is part of the NCI Innovative Molecular Analysis Technologies (IMAT) Program, with a closing date of September 26, 2017.
Opportunity ID: 289958
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-17-013 |
Funding Opportunity Title: | Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 07, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Sep 26, 2017 |
Current Closing Date for Applications: | Sep 26, 2017 |
Archive Date: | Oct 27, 2017 |
Estimated Total Program Funding: | $800,000 |
Award Ceiling: | $300,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Private institutions of higher education Small businesses City or township governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Public and State controlled institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00229090 | Jan 28, 2017 | Sep 26, 2017 | View |
Package 1
Mandatory forms
289958 RR_SF424_2_0-2.0.pdf
289958 PHS398_CoverPageSupplement_3_0-3.0.pdf
289958 RR_OtherProjectInfo_1_3-1.3.pdf
289958 PerformanceSite_2_0-2.0.pdf
289958 RR_KeyPersonExpanded_2_0-2.0.pdf
289958 RR_Budget_1_3-1.3.pdf
289958 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
289958 RR_SubawardBudget30_1_3-1.3.pdf
289958 PHS_Inclusion_Enrollment_Report-1.0.pdf
289958 PHS_AssignmentRequestForm-1.0.pdf